ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66 | -99.4% | 3,945 | +352.9% | 0.00% | – |
| Q3 2022 | $12,000 | -97.7% | 871 | -95.6% | 0.00% | – |
| Q1 2022 | $531,000 | +126.0% | 19,710 | +209.4% | 0.00% | – |
| Q4 2021 | $235,000 | +739.3% | 6,371 | +694.4% | 0.00% | – |
| Q3 2021 | $28,000 | -60.0% | 802 | -61.3% | 0.00% | – |
| Q2 2021 | $70,000 | -82.2% | 2,075 | -78.2% | 0.00% | -100.0% |
| Q1 2021 | $393,000 | +934.2% | 9,535 | +971.3% | 0.00% | – |
| Q4 2020 | $38,000 | +1166.7% | 890 | +959.5% | 0.00% | – |
| Q2 2020 | $3,000 | -93.0% | 84 | -97.4% | 0.00% | – |
| Q1 2020 | $43,000 | -70.1% | 3,224 | -75.7% | 0.00% | – |
| Q4 2019 | $144,000 | +13.4% | 13,292 | +7.0% | 0.00% | – |
| Q3 2019 | $127,000 | +477.3% | 12,420 | +413.0% | 0.00% | – |
| Q2 2019 | $22,000 | – | 2,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |